PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | Total Revenue | 7,898,000 | 7,298,000 | 7,975,000 | 9,225,000 | Cost of Revenue | 6,897,000 | 5,255,000 | 5,752,000 | 7,027,000 | | Gross Profit | 1,001,000 | 2,043,000 | 2,223,000 | 2,198,000 | | | Operating Expenses | | Research Development | 355,000 | 327,000 | 351,000 | 388,000 | | Selling General and Administrative | 1,325,000 | 1,183,000 | 1,253,000 | 1,706,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | Operating Income or Loss | (679,000) | 533,000 | 619,000 | 104,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 88,000 | 66,000 | 163,000 | 64,000 | | Earnings Before Interest And Taxes | (591,000) | 599,000 | 782,000 | 168,000 | | Interest Expense | (719,000) | 347,000 | 381,000 | 380,000 | | Income Before Tax | 128,000 | 252,000 | 401,000 | (212,000) | | Income Tax Expense | (91,000) | (139,000) | 40,000 | (80,000) | | Minority Interest | 26,000 | 42,000 | (19,000) | 19,000 | | | | Net Income From Continuing Ops | 232,000 | 434,000 | 341,000 | (112,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | Net Income | 232,000 | 434,000 | 341,000 | (112,000) | Preferred Stock And Other Adjustments |
-
| (30,000) | 30,000 |
-
| | Net Income Applicable To Common Shares | $232,000 | $404,000 | $371,000 | ($112,000) |
|